Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Vaccine Revenue

1.5 Market Analysis by Type

1.5.1 Global Vaccine Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Varicella Vaccine

1.5.3 Influenza Vaccine

1.5.4 Polio Vaccine

1.5.5 Hepatitis A Vaccine

1.5.6 Rabies Vaccine

1.5.7 BCG Vaccine

1.5.8 Hepatitis B

1.5.9 Pertussis, Diphtheria, tetanus

1.5.10 Pneumococcal

1.6 Market by Application

1.6.1 Global Vaccine Market Share by Application: 2022-2027

1.6.2 For Adult

1.6.3 For Child

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Vaccine Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Vaccine Market Players Profiles

3.1 AstraZeneca

3.1.1 AstraZeneca Company Profile

3.1.2 AstraZeneca Vaccine Product Specification

3.1.3 AstraZeneca Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 GSK

3.2.1 GSK Company Profile

3.2.2 GSK Vaccine Product Specification

3.2.3 GSK Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 CCBIO

3.3.1 CCBIO Company Profile

3.3.2 CCBIO Vaccine Product Specification

3.3.3 CCBIO Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 BioNTech

3.4.1 BioNTech Company Profile

3.4.2 BioNTech Vaccine Product Specification

3.4.3 BioNTech Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Elanco

3.5.1 Elanco Company Profile

3.5.2 Elanco Vaccine Product Specification

3.5.3 Elanco Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Boehringer-Ingelheim

3.6.1 Boehringer-Ingelheim Company Profile

3.6.2 Boehringer-Ingelheim Vaccine Product Specification

3.6.3 Boehringer-Ingelheim Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Indian Immunologicals

3.7.1 Indian Immunologicals Company Profile

3.7.2 Indian Immunologicals Vaccine Product Specification

3.7.3 Indian Immunologicals Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 CureVac

3.8.1 CureVac Company Profile

3.8.2 CureVac Vaccine Product Specification

3.8.3 CureVac Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 CSL

3.9.1 CSL Company Profile

3.9.2 CSL Vaccine Product Specification

3.9.3 CSL Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Hulan Bio

3.10.1 Hulan Bio Company Profile

3.10.2 Hulan Bio Vaccine Product Specification

3.10.3 Hulan Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Mylan

3.11.1 Mylan Company Profile

3.11.2 Mylan Vaccine Product Specification

3.11.3 Mylan Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Translate Bio

3.12.1 Translate Bio Company Profile

3.12.2 Translate Bio Vaccine Product Specification

3.12.3 Translate Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Merck

3.13.1 Merck Company Profile

3.13.2 Merck Vaccine Product Specification

3.13.3 Merck Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Wuhan Institute of Biological Products

3.14.1 Wuhan Institute of Biological Products Company Profile

3.14.2 Wuhan Institute of Biological Products Vaccine Product Specification

3.14.3 Wuhan Institute of Biological Products Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Plumbline Life Sciences

3.15.1 Plumbline Life Sciences Company Profile

3.15.2 Plumbline Life Sciences Vaccine Product Specification

3.15.3 Plumbline Life Sciences Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Moderna Therapeutics

3.16.1 Moderna Therapeutics Company Profile

3.16.2 Moderna Therapeutics Vaccine Product Specification

3.16.3 Moderna Therapeutics Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Minhai Biotechnology

3.17.1 Minhai Biotechnology Company Profile

3.17.2 Minhai Biotechnology Vaccine Product Specification

3.17.3 Minhai Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 Walvax Biotechnology

3.18.1 Walvax Biotechnology Company Profile

3.18.2 Walvax Biotechnology Vaccine Product Specification

3.18.3 Walvax Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.19 Sanofi

3.19.1 Sanofi Company Profile

3.19.2 Sanofi Vaccine Product Specification

3.19.3 Sanofi Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.20 Mitsubishi Tanabe Pharma

3.20.1 Mitsubishi Tanabe Pharma Company Profile

3.20.2 Mitsubishi Tanabe Pharma Vaccine Product Specification

3.20.3 Mitsubishi Tanabe Pharma Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.21 Zoties

3.21.1 Zoties Company Profile

3.21.2 Zoties Vaccine Product Specification

3.21.3 Zoties Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Vaccine Market Competition by Market Players

4.1 Global Vaccine Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Vaccine Revenue Market Share by Market Players (2016-2021)

4.3 Global Vaccine Average Price by Market Players (2016-2021)

5 Global Vaccine Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Vaccine Market Size (2016-2021)

5.1.2 Vaccine Key Players in North America (2016-2021)

5.1.3 North America Vaccine Market Size by Type (2016-2021)

5.1.4 North America Vaccine Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Vaccine Market Size (2016-2021)

5.2.2 Vaccine Key Players in East Asia (2016-2021)

5.2.3 East Asia Vaccine Market Size by Type (2016-2021)

5.2.4 East Asia Vaccine Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Vaccine Market Size (2016-2021)

5.3.2 Vaccine Key Players in Europe (2016-2021)

5.3.3 Europe Vaccine Market Size by Type (2016-2021)

5.3.4 Europe Vaccine Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Vaccine Market Size (2016-2021)

5.4.2 Vaccine Key Players in South Asia (2016-2021)

5.4.3 South Asia Vaccine Market Size by Type (2016-2021)

5.4.4 South Asia Vaccine Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Vaccine Market Size (2016-2021)

5.5.2 Vaccine Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Vaccine Market Size by Type (2016-2021)

5.5.4 Southeast Asia Vaccine Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Vaccine Market Size (2016-2021)

5.6.2 Vaccine Key Players in Middle East (2016-2021)

5.6.3 Middle East Vaccine Market Size by Type (2016-2021)

5.6.4 Middle East Vaccine Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Vaccine Market Size (2016-2021)

5.7.2 Vaccine Key Players in Africa (2016-2021)

5.7.3 Africa Vaccine Market Size by Type (2016-2021)

5.7.4 Africa Vaccine Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Vaccine Market Size (2016-2021)

5.8.2 Vaccine Key Players in Oceania (2016-2021)

5.8.3 Oceania Vaccine Market Size by Type (2016-2021)

5.8.4 Oceania Vaccine Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Vaccine Market Size (2016-2021)

5.9.2 Vaccine Key Players in South America (2016-2021)

5.9.3 South America Vaccine Market Size by Type (2016-2021)

5.9.4 South America Vaccine Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Vaccine Market Size (2016-2021)

5.10.2 Vaccine Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Vaccine Market Size by Type (2016-2021)

5.10.4 Rest of the World Vaccine Market Size by Application (2016-2021)

6 Global Vaccine Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Vaccine Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Vaccine Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Vaccine Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Vaccine Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Vaccine Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Vaccine Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Vaccine Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Vaccine Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Vaccine Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Vaccine Consumption by Countries

7 Global Vaccine Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Vaccine (2022-2027)

7.2 Global Forecasted Revenue of Vaccine (2022-2027)

7.3 Global Forecasted Price of Vaccine (2022-2027)

7.4 Global Forecasted Production of Vaccine by Region (2022-2027)

7.4.1 North America Vaccine Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Vaccine Production, Revenue Forecast (2022-2027)

7.4.3 Europe Vaccine Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Vaccine Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Vaccine Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Vaccine Production, Revenue Forecast (2022-2027)

7.4.7 Africa Vaccine Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Vaccine Production, Revenue Forecast (2022-2027)

7.4.9 South America Vaccine Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Vaccine Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Vaccine by Application (2022-2027)

8 Global Vaccine Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Vaccine by Country

8.2 East Asia Market Forecasted Consumption of Vaccine by Country

8.3 Europe Market Forecasted Consumption of Vaccine by Countriy

8.4 South Asia Forecasted Consumption of Vaccine by Country

8.5 Southeast Asia Forecasted Consumption of Vaccine by Country

8.6 Middle East Forecasted Consumption of Vaccine by Country

8.7 Africa Forecasted Consumption of Vaccine by Country

8.8 Oceania Forecasted Consumption of Vaccine by Country

8.9 South America Forecasted Consumption of Vaccine by Country

8.10 Rest of the world Forecasted Consumption of Vaccine by Country

9 Global Vaccine Sales by Type (2016-2027)

9.1 Global Vaccine Historic Market Size by Type (2016-2021)

9.2 Global Vaccine Forecasted Market Size by Type (2022-2027)

10 Global Vaccine Consumption by Application (2016-2027)

10.1 Global Vaccine Historic Market Size by Application (2016-2021)

10.2 Global Vaccine Forecasted Market Size by Application (2022-2027)

11 Global Vaccine Manufacturing Cost Analysis

11.1 Vaccine Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Vaccine

12 Global Vaccine Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Vaccine Distributors List

12.3 Vaccine Customers

12.4 Vaccine Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Vaccine Revenue (US$ Million) 2016-2021

Table 6. Global Vaccine Market Size by Type (US$ Million): 2022-2027

Table 7. Varicella Vaccine Features

Table 8. Influenza Vaccine Features

Table 9. Polio Vaccine Features

Table 10. Hepatitis A Vaccine Features

Table 11. Rabies Vaccine Features

Table 12. BCG Vaccine Features

Table 13. Hepatitis B Features

Table 14. Pertussis, Diphtheria, tetanus Features

Table 15. Pneumococcal Features

Table 16. Global Vaccine Market Size by Application (US$ Million): 2022-2027

Table 17. For Adult Case Studies

Table 18. For Child Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Vaccine Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Vaccine Market Growth Strategy

Table 46. Vaccine SWOT Analysis

Table 47. AstraZeneca Vaccine Product Specification

Table 48. AstraZeneca Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. GSK Vaccine Product Specification

Table 50. GSK Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. CCBIO Vaccine Product Specification

Table 52. CCBIO Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. BioNTech Vaccine Product Specification

Table 54. Table BioNTech Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Elanco Vaccine Product Specification

Table 56. Elanco Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Boehringer-Ingelheim Vaccine Product Specification

Table 58. Boehringer-Ingelheim Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Indian Immunologicals Vaccine Product Specification

Table 60. Indian Immunologicals Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. CureVac Vaccine Product Specification

Table 62. CureVac Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. CSL Vaccine Product Specification

Table 64. CSL Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Hulan Bio Vaccine Product Specification

Table 66. Hulan Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Mylan Vaccine Product Specification

Table 68. Mylan Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Translate Bio Vaccine Product Specification

Table 70. Translate Bio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Merck Vaccine Product Specification

Table 72. Merck Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Wuhan Institute of Biological Products Vaccine Product Specification

Table 74. Wuhan Institute of Biological Products Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. Plumbline Life Sciences Vaccine Product Specification

Table 76. Plumbline Life Sciences Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Moderna Therapeutics Vaccine Product Specification

Table 78. Moderna Therapeutics Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Minhai Biotechnology Vaccine Product Specification

Table 80. Minhai Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 81. Walvax Biotechnology Vaccine Product Specification

Table 82. Walvax Biotechnology Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 83. Sanofi Vaccine Product Specification

Table 84. Sanofi Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 85. Mitsubishi Tanabe Pharma Vaccine Product Specification

Table 86. Mitsubishi Tanabe Pharma Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 87. Zoties Vaccine Product Specification

Table 88. Zoties Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Vaccine Production Capacity by Market Players

Table 148. Global Vaccine Production by Market Players (2016-2021)

Table 149. Global Vaccine Production Market Share by Market Players (2016-2021)

Table 150. Global Vaccine Revenue by Market Players (2016-2021)

Table 151. Global Vaccine Revenue Share by Market Players (2016-2021)

Table 152. Global Market Vaccine Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Vaccine Market Share (2016-2021)

Table 155. North America Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Vaccine Market Share by Type (2016-2021)

Table 157. North America Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Vaccine Market Share by Application (2016-2021)

Table 159. East Asia Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Vaccine Market Share (2016-2021)

Table 162. East Asia Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Vaccine Market Share by Type (2016-2021)

Table 164. East Asia Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Vaccine Market Share by Application (2016-2021)

Table 166. Europe Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Vaccine Market Share (2016-2021)

Table 169. Europe Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Vaccine Market Share by Type (2016-2021)

Table 171. Europe Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Vaccine Market Share by Application (2016-2021)

Table 173. South Asia Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Vaccine Market Share (2016-2021)

Table 176. South Asia Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Vaccine Market Share by Type (2016-2021)

Table 178. South Asia Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Vaccine Market Share by Application (2016-2021)

Table 180. Southeast Asia Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Vaccine Market Share (2016-2021)

Table 183. Southeast Asia Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Vaccine Market Share by Type (2016-2021)

Table 185. Southeast Asia Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Vaccine Market Share by Application (2016-2021)

Table 187. Middle East Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Vaccine Market Share (2016-2021)

Table 190. Middle East Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Vaccine Market Share by Type (2016-2021)

Table 192. Middle East Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Vaccine Market Share by Application (2016-2021)

Table 194. Africa Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Vaccine Market Share (2016-2021)

Table 197. Africa Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Vaccine Market Share by Type (2016-2021)

Table 199. Africa Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Vaccine Market Share by Application (2016-2021)

Table 201. Oceania Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Vaccine Market Share (2016-2021)

Table 204. Oceania Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Vaccine Market Share by Type (2016-2021)

Table 206. Oceania Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Vaccine Market Share by Application (2016-2021)

Table 208. South America Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Vaccine Market Share (2016-2021)

Table 211. South America Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Vaccine Market Share by Type (2016-2021)

Table 213. South America Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Vaccine Market Share by Application (2016-2021)

Table 215. Rest of the World Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Vaccine Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Vaccine Market Share (2016-2021)

Table 218. Rest of the World Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Vaccine Market Share by Type (2016-2021)

Table 220. Rest of the World Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Vaccine Market Share by Application (2016-2021)

Table 222. North America Vaccine Consumption by Countries (2016-2021)

Table 223. East Asia Vaccine Consumption by Countries (2016-2021)

Table 224. Europe Vaccine Consumption by Region (2016-2021)

Table 225. South Asia Vaccine Consumption by Countries (2016-2021)

Table 226. Southeast Asia Vaccine Consumption by Countries (2016-2021)

Table 227. Middle East Vaccine Consumption by Countries (2016-2021)

Table 228. Africa Vaccine Consumption by Countries (2016-2021)

Table 229. Oceania Vaccine Consumption by Countries (2016-2021)

Table 230. South America Vaccine Consumption by Countries (2016-2021)

Table 231. Rest of the World Vaccine Consumption by Countries (2016-2021)

Table 232. Global Vaccine Production Forecast by Region (2022-2027)

Table 233. Global Vaccine Sales Volume Forecast by Type (2022-2027)

Table 234. Global Vaccine Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Vaccine Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Vaccine Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Vaccine Sales Price Forecast by Type (2022-2027)

Table 238. Global Vaccine Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Vaccine Consumption Value Forecast by Application (2022-2027)

Table 240. North America Vaccine Consumption Forecast 2022-2027 by Country

Table 241. East Asia Vaccine Consumption Forecast 2022-2027 by Country

Table 242. Europe Vaccine Consumption Forecast 2022-2027 by Country

Table 243. South Asia Vaccine Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Vaccine Consumption Forecast 2022-2027 by Country

Table 245. Middle East Vaccine Consumption Forecast 2022-2027 by Country

Table 246. Africa Vaccine Consumption Forecast 2022-2027 by Country

Table 247. Oceania Vaccine Consumption Forecast 2022-2027 by Country

Table 248. South America Vaccine Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Vaccine Consumption Forecast 2022-2027 by Country

Table 250. Global Vaccine Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Vaccine Revenue Market Share by Type (2016-2021)

Table 252. Global Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Vaccine Revenue Market Share by Type (2022-2027)

Table 254. Global Vaccine Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Vaccine Revenue Market Share by Application (2016-2021)

Table 256. Global Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Vaccine Revenue Market Share by Application (2022-2027)

Table 258. Vaccine Distributors List

Table 259. Vaccine Customers List





Figure 1. Product Figure

Figure 2. Global Vaccine Market Share by Type: 2021 VS 2027

Figure 3. Global Vaccine Market Share by Application: 2021 VS 2027

Figure 4. North America Vaccine Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Vaccine Consumption and Growth Rate (2016-2021)

Figure 6. North America Vaccine Consumption Market Share by Countries in 2021

Figure 7. United States Vaccine Consumption and Growth Rate (2016-2021)

Figure 8. Canada Vaccine Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Vaccine Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Vaccine Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Vaccine Consumption Market Share by Countries in 2021

Figure 12. China Vaccine Consumption and Growth Rate (2016-2021)

Figure 13. Japan Vaccine Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Vaccine Consumption and Growth Rate (2016-2021)

Figure 15. Europe Vaccine Consumption and Growth Rate

Figure 16. Europe Vaccine Consumption Market Share by Region in 2021

Figure 17. Germany Vaccine Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Vaccine Consumption and Growth Rate (2016-2021)

Figure 19. France Vaccine Consumption and Growth Rate (2016-2021)

Figure 20. Italy Vaccine Consumption and Growth Rate (2016-2021)

Figure 21. Russia Vaccine Consumption and Growth Rate (2016-2021)

Figure 22. Spain Vaccine Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Vaccine Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Vaccine Consumption and Growth Rate (2016-2021)

Figure 25. Poland Vaccine Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Vaccine Consumption and Growth Rate

Figure 27. South Asia Vaccine Consumption Market Share by Countries in 2021

Figure 28. India Vaccine Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Vaccine Consumption and Growth Rate

Figure 30. Southeast Asia Vaccine Consumption Market Share by Countries in 2021

Figure 31. Indonesia Vaccine Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Vaccine Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Vaccine Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Vaccine Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Vaccine Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Vaccine Consumption and Growth Rate

Figure 37. Middle East Vaccine Consumption Market Share by Countries in 2021

Figure 38. Turkey Vaccine Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Vaccine Consumption and Growth Rate (2016-2021)

Figure 40. Iran Vaccine Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Vaccine Consumption and Growth Rate (2016-2021)

Figure 42. Africa Vaccine Consumption and Growth Rate

Figure 43. Africa Vaccine Consumption Market Share by Countries in 2021

Figure 44. Nigeria Vaccine Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Vaccine Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Vaccine Consumption and Growth Rate

Figure 47. Oceania Vaccine Consumption Market Share by Countries in 2021

Figure 48. Australia Vaccine Consumption and Growth Rate (2016-2021)

Figure 49. South America Vaccine Consumption and Growth Rate

Figure 50. South America Vaccine Consumption Market Share by Countries in 2021

Figure 51. Brazil Vaccine Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Vaccine Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Vaccine Consumption and Growth Rate

Figure 54. Rest of the World Vaccine Consumption Market Share by Countries in 2021

Figure 55. Global Vaccine Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Vaccine Price and Trend Forecast (2022-2027)

Figure 58. North America Vaccine Production Growth Rate Forecast (2022-2027)

Figure 59. North America Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Vaccine Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Vaccine Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Vaccine Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Vaccine Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Vaccine Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Vaccine Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Vaccine Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Vaccine Production Growth Rate Forecast (2022-2027)

Figure 75. South America Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Vaccine Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Vaccine Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Vaccine Consumption Forecast 2022-2027

Figure 79. East Asia Vaccine Consumption Forecast 2022-2027

Figure 80. Europe Vaccine Consumption Forecast 2022-2027

Figure 81. South Asia Vaccine Consumption Forecast 2022-2027

Figure 82. Southeast Asia Vaccine Consumption Forecast 2022-2027

Figure 83. Middle East Vaccine Consumption Forecast 2022-2027

Figure 84. Africa Vaccine Consumption Forecast 2022-2027

Figure 85. Oceania Vaccine Consumption Forecast 2022-2027

Figure 86. South America Vaccine Consumption Forecast 2022-2027

Figure 87. Rest of the world Vaccine Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Vaccine

Figure 89. Manufacturing Process Analysis of Vaccine

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Vaccine Supply Chain Analysis